ImmUniverse partners engage at UEG Week 2025 in Berlin

The ImmUniverse consortium was delighted to be strongly represented at this year’s UEG Week 2025 in Berlin, one of the world’s leading events in the field of gastroenterology. The conference brought together clinicians, researchers, and patient organisations from across Europe to exchange insights and explore innovations shaping the future of care for people living with inflammatory bowel disease (IBD).

🔬 Scientific Highlights
Among the scientific contributions, Samuel Elias Pineda Chavez from Humanitas University presented his research during the inaugural DDM Summit, focussing on the potential of Low-Intensity Pulsed Ultrasound (LIPUS) as a novel non-invasive disruptive technology to improve monitoring of ulcerative colitis (UC). His presentation, supported by our coordinator Professor Stefania Vetrano and the Humanitas team, showcased how ImmUniverse partners are advancing non-invasive approaches to monitor disease activity and improve patient care.

💬 Patient Engagement Highlights
Our partner IFCCA (International Federation of Crohn’s and Ulcerative Colitis Associations) hosted a special IFCCA Youth Session at UEG Week titled “Living with IBD: Voices of Young Adults (18–30)”. During this interactive event, IFCCA presented the results of their Youth Group survey on IBD, conducted in collaboration with the Gastroenterology - Hepatology Department, Aristotle University of Thessaloniki (Hippokration Hospital).

The session shed light on the real-life experiences, challenges, and needs of young people living with IBD, offering insights to guide future advocacy and awareness efforts. Participants also had the opportunity to connect directly with the IFCCA Youth Group, share their experiences, and visit the IFCCA stand to learn more about ongoing projects and collaborations.

🤝 A Week of Collaboration and Inspiration
ImmUniverse extends its warm thanks to all partners and organisers who made UEG Week 2025 such an engaging and inspiring event. The consortium’s presence, spanning scientific innovation, patient representation, and cross-sector collaboration, reflects its core mission: to deepen understanding of immune-mediated diseases and improve life for those affected by them.